CIK 0002023658
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-03 | Raben David Chief Medical Officer | Sale 10b5-1 | −200 | $18.45 | $4K | 55,286 |
| 2026-02-25 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −3,108 | $18.04 | $56K | 210,164 |
| 2026-02-25 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −523 | $18.04 | $9K | 209,641 |
| 2026-01-22 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −3,828 | $18.10 | $69K | 210,164 |
| 2026-01-22 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −1,882 | $18.15 | $34K | 145,355 |
| 2026-01-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −149 | $18.02 | $3K | 213,992 |
| 2025-12-22 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −9,200 | $18.31 | $168K | 145,355 |
| 2025-12-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $18.68 | $149K | 193,641 |
| 2025-12-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $18.68 | $84K | 189,141 |
| 2025-11-25 | Raben David Chief Medical Officer | Sale 10b5-1 | −4,594 | $18.84 | $87K | 35,497 |
| 2025-11-25 | Raben David Chief Medical Officer | Sale 10b5-1 | −906 | $18.84 | $17K | 35,497 |
| 2025-11-24 | Raben David Chief Medical Officer | Sale 10b5-1 | −5,500 | $18.45 | $101K | 35,497 |
| 2025-11-24 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −41,163 | $18.86 | $776K | 309,892 |
| 2025-11-24 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −17,795 | $18.55 | $330K | 145,355 |
| 2025-11-21 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −605 | $18.15 | $11K | 145,355 |
| 2025-11-21 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $18.05 | $144K | 198,141 |
| 2025-11-21 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $18.05 | $81K | 193,641 |
| 2025-10-16 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −24,103 | $18.83 | $454K | 309,892 |
| 2025-10-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $18.16 | $145K | 202,641 |
| 2025-10-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $18.16 | $82K | 198,141 |
Page 3 of 4 · 76 trades